Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | CD20 CAR-T cells |
| Synonyms | |
| Therapy Description |
CD20 CAR-T cells are T-cells engineered to express a chimeric antigen receptor (CAR) targeting CD20, which potentially induce toxicity against CD20-expressing tumor cells and inhibit tumor growth (PMID: 25492700). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| CD20 CAR-T cells | anti-CD20 CAR|CD20 CAR T-cells|C-CAR066|CMB.CD20 CAR T C-CAR066 | CD20 Immune Cell Therapy 14 | CD20 CAR-T cells are T-cells engineered to express a chimeric antigen receptor (CAR) targeting CD20, which potentially induce toxicity against CD20-expressing tumor cells and inhibit tumor growth (PMID: 25492700). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|